One of the single most prevalent diseases that we are facing in America right now is cancer in all of its various forms. Nearly 40 percent of American adults will face a cancer diagnosis within their lifetimes and almost everyone knows someone who has gone through the cancer battle themselves.
One of the biggest issues with cancer and its treatment is the flow of information has been seriously impeded for many decades. Much of the most important information regarding a patient and their treatment is done freehand by the physician in a blank section set aside for this purpose. The problem has been how to streamline that data into a collective database.
That problem is swiftly seeing a remedy with Tempus, Co-founded by Eric Lefkofsky. Tempus is a revolutionary program that is serving a variety of needs within the medical field. One of the most important ways that Tempus is changing the way that cancer treatments are being delivered is through the optical recognition of native handwriting.
This new scanning process enabled Tempus to read the physician’s hand written notes on the patient and store them into a database in an easy to read format. This alone will branch out of just cancer treatment and will change the way a whole range of diseases will be monitored and treated.
Another profound way that Tempus is helping to change the way that cancer treatment is being delivered is through its ability to scan and store collected data on human genome mapping. This is important because most of cancer research today is being done on how to prevent and treat the disease on a molecular level.
Eric Lefkofsky is a graduate of the University of Michigan in Ann Arbor and went on to receive his Juris Doctor degree from the University of Michigan Law School but his life’s path would not take him down the path of a legal career.
Initially, Eric was swept up in the dot-com revolution and before long he found himself to be a power player and when his wife was diagnosed with breast cancer, it changed his life in many ways. It was at this point when he saw the huge gap in the medical field and how to bridge it.